Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4330) 4330
Publication (417) 417
Dissertation (32) 32
Book Review (13) 13
Book Chapter (8) 8
Conference Proceeding (6) 6
Government Document (2) 2
Magazine Article (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mmp-9 (3540) 3540
humans (2139) 2139
index medicus (2103) 2103
expression (1421) 1421
matrix metalloproteinases (1307) 1307
matrix metalloproteinase 9 - metabolism (1263) 1263
female (1226) 1226
male (1121) 1121
animals (1097) 1097
oncology (876) 876
metastasis (850) 850
invasion (789) 789
matrix metalloproteinase 9 - genetics (760) 760
middle aged (697) 697
mice (633) 633
cell line, tumor (607) 607
cancer (604) 604
adult (601) 601
mmp-2 (599) 599
activation (551) 551
matrix-metalloproteinase-9 (547) 547
cell biology (545) 545
aged (526) 526
biochemistry & molecular biology (507) 507
immunohistochemistry (479) 479
matrix metalloproteinase 2 - metabolism (441) 441
apoptosis (434) 434
angiogenesis (419) 419
gene expression (406) 406
cells (402) 402
inflammation (400) 400
matrix metalloproteinase (399) 399
proteins (398) 398
analysis (384) 384
migration (364) 364
pharmacology & pharmacy (350) 350
neoplasm invasiveness (342) 342
prognosis (337) 337
rats (332) 332
neurosciences (320) 320
gelatinase b (313) 313
medicine, research & experimental (313) 313
gene-expression (307) 307
breast cancer (301) 301
tissue inhibitor (299) 299
research (294) 294
timp-1 (291) 291
matrix metalloproteinase 9 - biosynthesis (286) 286
carcinoma (274) 274
growth (273) 273
in-vitro (273) 273
matrix metalloproteinase-9 (271) 271
matrix metalloproteinase 9 - blood (259) 259
cell movement - drug effects (253) 253
nf-kappa-b (252) 252
cells, cultured (246) 246
tumors (246) 246
inhibition (243) 243
signal transduction (243) 243
immunology (241) 241
up-regulation (238) 238
health aspects (235) 235
pathology (232) 232
care and treatment (225) 225
article (224) 224
development and progression (219) 219
metalloproteinase (216) 216
proliferation (213) 213
blotting, western (212) 212
inhibitors (211) 211
progression (210) 210
rna, messenger - metabolism (207) 207
disease models, animal (202) 202
aged, 80 and over (199) 199
matrix metalloproteinase 2 - genetics (199) 199
disease (198) 198
enzymes (198) 198
genetic aspects (198) 198
down-regulation (197) 197
enzyme-linked immunosorbent assay (196) 196
gene expression regulation, neoplastic (193) 193
mmp-9 expression (193) 193
tissue inhibitors (193) 193
kinases (186) 186
extracellular matrix (184) 184
reverse transcriptase polymerase chain reaction (182) 182
studies (182) 182
surgery (182) 182
signal transduction - drug effects (179) 179
phosphorylation (177) 177
nf-kappa b - metabolism (176) 176
cell proliferation (174) 174
breast-cancer (173) 173
extracellular-matrix (171) 171
nf-κb (167) 167
iv collagenase (165) 165
medicine (165) 165
cytokines (164) 164
collagen (161) 161
breast neoplasms - pathology (160) 160
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4258) 4258
Korean (28) 28
Chinese (23) 23
Japanese (16) 16
German (9) 9
Polish (8) 8
Russian (8) 8
Spanish (7) 7
Portuguese (4) 4
French (3) 3
Arabic (1) 1
Persian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies
by Zhou, Jian and Liu, Tang and Wang, Wanchun
Medicine, ISSN 0025-7974, 11/2018, Volume 97, Issue 44, p. e13051
Background: Matrix metalloproteinase 9 (MMP-9) is significant in the progression of osteosarcoma (OS) via increasing tumor growth, invasion and metastasis.... 
SURVIVAL | MEDICINE, GENERAL & INTERNAL | BIOMARKER | metastasis | MATRIX METALLOPROTEINASE-1 | POOR-PROGNOSIS | meta-analysis | overall survival | TISSUE INHIBITOR | MMP-9 | CANCER | osteosarcoma | Bone Neoplasms - mortality | Matrix Metalloproteinase 9 - metabolism | Osteosarcoma - mortality | Prognosis | Humans | Biomarkers, Tumor - metabolism | Survival Rate | Osteosarcoma - metabolism | Bone Neoplasms - metabolism | Osteosarcoma | Physiological aspects | Development and progression | Metastasis | Metalloenzymes | Biological markers | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Female Hormone 17β-Estradiol Downregulated MMP-2 Expression and Upregulated A1PI Expression in Human Corneal Stromal Cells
by Yin, Hongbo and Wan, Qi and Tian, Yan and Zhao, Bo and Deng, Yingping
Cell Biochemistry and Biophysics, ISSN 1085-9195, 06/2018, Volume 76, Issue 1-2, pp. 265 - 271
Collagens are essential for cornea functions. In non-ocular tissues, it has been demonstrated that sex hormones modulate the collagen remodeling. In this... 
Corneal stromal cell | MMP-2 | 17β-estrodiol | SP1 | MMP-9 | A1PI | MENSTRUAL-CYCLE | TRANSCRIPTION FACTORS | PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | KERATOCONUS | CELL BIOLOGY | ALPHA-1-PROTEINASE INHIBITOR GENE | BIOPHYSICS | MATRIX-METALLOPROTEINASES | ESTROGEN | PROMOTER | THICKNESS | 17 beta-estrodiol | Cornea | Matrix metalloproteinases | Proteinase | Collagens | Proteinase inhibitors | Hormones | Matrix metalloproteinase | Gene expression | Estradiol | Gelatinase A | Proteins | Sex hormones | Inhibitors | Stromal cells | Collagen | Extracellular matrix | Degeneration | Hormone replacement therapy | Metalloproteinase | Viability | Apoptosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text MMP-9 expression varies according to molecular subtypes of breast cancer
by Yousef, Einas M and Tahir, Muhammad R and St-Pierre, Yves and Gaboury, Louis A
BMC Cancer, ISSN 1471-2407, 08/2014, Volume 14, Issue 1, p. 609
Background: In 2014, breast cancer remains a major cause of mortality worldwide mostly due to tumor relapse and metastasis. There is currently a great interest... 
Metastasis | Human breast cancers | Tissue microarrays | MMP-9 | In silico analysis | TISSUE | CELL-LINES | MATRIX METALLOPROTEINASES | MODELS | ONCOLOGY | MATRIX-METALLOPROTEINASE-9 MMP-9 | GENE-EXPRESSION | PROGNOSTIC-SIGNIFICANCE | INHIBITORS | PROGRESSION | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Survival Rate | Lymphatic Metastasis | Matrix Metalloproteinase 9 - metabolism | Breast Neoplasms - genetics | MCF-7 Cells | Breast Neoplasms - pathology | Matrix Metalloproteinase 9 - genetics | Cell Line, Tumor | Breast Neoplasms - mortality | Female | Retrospective Studies | Usage | DNA microarrays | Proteases | Physiological aspects | Development and progression | Breast cancer | Research | Life Sciences | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Melatonin suppresses TPA‐induced metastasis by downregulating matrix metalloproteinase‐9 expression through JNK/SP‐1 signaling in nasopharyngeal carcinoma
by Ho, Hsin‐Yu and Lin, Chiao‐Wen and Chien, Ming‐Hsien and Reiter, Russel J and Su, Shih‐Chi and Hsieh, Yi‐Hsien and Yang, Shun‐Fa
Journal of Pineal Research, ISSN 0742-3098, 11/2016, Volume 61, Issue 4, pp. 479 - 492
Nasopharyngeal carcinoma ( NPC ), a disease common in the South‐East Asian population, has high lymph node metastatic ability. Melatonin, an endogenously... 
MMP | nasopharyngeal carcinoma | melatonin | metastasis | SP-1 | PHYSIOLOGY | MMP-9 EXPRESSION | FACTOR-KAPPA-B | MATRIX METALLOPROTEINASE-2 | MAPK | PROGNOSTIC VALUE | NEUROSCIENCES | LYMPH-NODE METASTASIS | GASTRIC-CANCER | POOR-PROGNOSIS | ENDOCRINOLOGY & METABOLISM | DEPENDENT UP-REGULATION | CANCER CELL INVASION | Gene Expression Regulation, Enzymologic - drug effects | Matrix Metalloproteinase 9 - biosynthesis | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms - metabolism | Carcinoma | Tetradecanoylphorbol Acetate - pharmacology | Humans | Sp1 Transcription Factor - metabolism | Down-Regulation - drug effects | Neoplasm Proteins - metabolism | Nasopharyngeal Neoplasms - pathology | Neoplasm Metastasis | MAP Kinase Kinase 4 - metabolism | Signal Transduction - drug effects | Cell Line, Tumor | Gene Expression Regulation, Neoplastic - drug effects | Nasopharyngeal Neoplasms - drug therapy | Melatonin - pharmacology | Epigenetic inheritance | Melatonin | Analysis | Genetic research | Genetic transcription | Metastasis | Protein kinases | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text (−)‐Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor‐1 to inhibit migration, adhesion, and invasion of MDA‐MB‐231 cells
by Shin, Sunhye and Kim, Mi Kyoung and Jung, Woong and Chong, Youhoon
Phytotherapy Research, ISSN 0951-418X, 10/2018, Volume 32, Issue 10, pp. 2086 - 2096
Urokinase plasminogen activator (uPA) and its inhibitor plasminogen activator inhibitor‐1 (PAI‐1) are established independent biomarkers for high metastasis... 
breast cancer | system | metastasis | EGCG | uPA | uPA system | ADJUVANT CHEMOTHERAPY | CHEMISTRY, MEDICINAL | MMP-9 EXPRESSION | RNA APTAMERS | TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE | HUMAN ENDOTHELIAL-CELLS | CLINICAL-RELEVANCE | GREEN TEA | SIGNALING PATHWAY | BREAST-CANCER PATIENTS | PHARMACOLOGY & PHARMACY | NF-KAPPA-B | Signal Transduction | Neoplasm Invasiveness | Humans | Cell Adhesion | Breast Neoplasms - metabolism | Plasminogen Activator Inhibitor 1 - metabolism | Urokinase-Type Plasminogen Activator - metabolism | Breast Neoplasms - pathology | Cell Line, Tumor | Female | Catechin - analogs & derivatives | Plasminogen | Catechin - pharmacology | Cell Movement | Catechin | Metastasis | Thrombolytic drugs | Mitogens | Epigallocatechin-3-gallate | Health risks | Extracellular signal-regulated kinase | MAP kinase | AKT protein | Breast cancer | Derivatives | Kinases | Adhesion | 1-Phosphatidylinositol 3-kinase | Metastases | U-Plasminogen activator | Proteins | Urokinase | Reduction | Epigallocatechin gallate | Inhibitors | Protein kinase | Plasminogen activator inhibitors | Biomarkers | Bioindicators | Cell migration | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Cadmium induces matrix metalloproteinase-9 expression via ROS-dependent EGFR, NF-κB, and AP-1 pathways in human endothelial cells
by Lian, Sen and Xia, Yong and Khoi, Pham Ngoc and Ung, Trong Thuan and Yoon, Hyun Joong and Kim, Nam Ho and Kim, Kyung Keun and Jung, Young Do
Toxicology, ISSN 0300-483X, 12/2015, Volume 338, pp. 104 - 116
Cadmium (Cd), a widespread cumulative pollutant, is a known human carcinogen, associated with inflammation and tumors. Matrix metalloproteinase-9 (MMP-9) plays... 
Cadmium | Cell invasion | MMP-9 | Endothelial cells | NADPH OXIDASE | SIGNALING PATHWAYS | OXIDATIVE STRESS | MMP-9 EXPRESSION | CARCINOMA CELLS | CANCER CELLS | NECROSIS-FACTOR-ALPHA | REACTIVE OXYGEN | EPITHELIAL-CELLS | PHARMACOLOGY & PHARMACY | CELLULAR MECHANISMS | TOXICOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Prognostic significance of MMP‐9 and TIMP‐1 serum and tissue expression in breast cancer
by Wu, Zheng‐Sheng and Wu, Qiang and Yang, Jiu‐Hua and Wang, Hong‐Qun and Ding, Xiang‐Dong and Yang, Feng and Xu, Xiao‐Chun
International Journal of Cancer, ISSN 0020-7136, 05/2008, Volume 122, Issue 9, pp. 2050 - 2056
Tumor progression and metastasis contribute to the great majority of breast cancer deaths. Matrix metalloproteinases (MMPs) and tissue inhibitors of... 
breast cancer | TIMP‐1 | patient survival | MMP‐9 | serum biomarker | Breast cancer | Serum biomarker | TIMP-1 | MMP-9 | Patient survival | SURVIVAL | LUNG | CELL CARCINOMA | INVASION | ONCOLOGY | MATRIX METALLOPROTEINASE-1 | IMMUNOREACTIVE PROTEIN | GELATINASE-B | MATRIX-METALLOPROTEINASE-9 | GRADE | INHIBITOR | Immunohistochemistry | Predictive Value of Tests | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Receptors, Estrogen - analysis | RNA, Messenger - metabolism | Receptors, Progesterone - analysis | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Breast Neoplasms - chemistry | Breast Neoplasms - enzymology | Matrix Metalloproteinase 9 - metabolism | In Situ Hybridization | Matrix Metalloproteinase 9 - genetics | Breast Diseases - enzymology | Biomarkers, Tumor - metabolism | Adult | Female | Matrix Metalloproteinase 9 - blood | Tissue Inhibitor of Metalloproteinase-1 - blood | Enzyme-Linked Immunosorbent Assay | Lymphatic Metastasis | Biomarkers, Tumor - blood | Gene Expression Regulation, Enzymologic | Tissue Inhibitor of Metalloproteinase-1 - genetics | Breast Neoplasms - pathology | Survival Analysis | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer
by Lee, Myung A and Park, Jin-Hee and Rhyu, Si Y and Oh, Seong-Taek and Kang, Won-Kyoung and Kim, Hee-Na
BMC Cancer, ISSN 1471-2407, 02/2014, Volume 14, Issue 1, pp. 125 - 125
Background: The wnt beta-catenin signaling pathway is known to affect in cancer oncogenesis and progression by interacting with the tumor microenvironment.... 
β-catenin | Wnt5a | MMP-9 | VEGFR-2 | Wnt3a | Colorectal cancer | beta-catenin | MIGRATION | STEM-CELLS | ACTIVATION | PROLIFERATION | INVASION | ONCOLOGY | WNT/BETA-CATENIN | PATHWAY | GROWTH | CROSSTALK | BETA-CATENIN EXPRESSION | Matrix Metalloproteinase 9 - biosynthesis | Wnt3A Protein - genetics | Neoplasm Recurrence, Local - metabolism | Colorectal Neoplasms - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Neoplasm Recurrence, Local - diagnosis | Colorectal Neoplasms - diagnosis | Neoplasm Recurrence, Local - pathology | Wnt3A Protein - biosynthesis | Matrix Metalloproteinase 9 - genetics | Adult | Female | Aged | Neoplasm Staging | Colorectal Neoplasms - metabolism | Development and progression | Genetic aspects | Cellular signal transduction | Metastasis | Cancer invasiveness | Gene expression
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text 7‐Methoxy‐luteolin‐8‐C‐β‐6‐deoxy‐xylo‐pyranos‐3‐uloside exactly (mLU8C‐PU) isolated from Arthraxon hispidus inhibits migratory and invasive responses mediated via downregulation of MMP‐9 and IL‐8 expression in MCF‐7 breast cancer cells
by Kim, Soo‐Jin and Pham, Thu‐Huyen and Bak, Yesol and Ryu, Hyung‐Won and Oh, Sei‐Ryang and Yoon, Do‐Young
Environmental Toxicology, ISSN 1520-4081, 11/2018, Volume 33, Issue 11, pp. 1143 - 1152
7‐Methoxy‐luteolin‐8‐C‐ β ‐6‐deoxy‐xylo‐pyranos‐3‐uloside (mLU8C‐PU) is a glycosylflavone of luteolin isolated from Arthraxon hispidus (Thunb.). Luteolin is... 
invasion | MMP‐9 | Arthraxon hispidus | IL‐8 | JNK | IL-8 | MMP-9 | TPA-INDUCED MMP-9 | ACTIVATION | METASTASIS | ADENOCARCINOMA CELLS | ALPHA | WATER RESOURCES | ERK SIGNALING PATHWAY | MATRIX METALLOPROTEINASES | ENVIRONMENTAL SCIENCES | EPITHELIAL-CELLS | SUPPRESSES | TOXICOLOGY | NF-KAPPA-B | Interleukin-8 - genetics | Protein Kinase C-alpha - metabolism | Plant Extracts - pharmacology | Humans | Protein Kinase C-alpha - genetics | Cell Movement - genetics | Breast Neoplasms - metabolism | Matrix Metalloproteinase 9 - metabolism | MCF-7 Cells | Luteolin - chemistry | Matrix Metalloproteinase 9 - genetics | Poaceae - chemistry | Female | Gene Expression Regulation, Neoplastic - drug effects | Interleukin-8 - metabolism | Phosphorylation - drug effects | Cell Adhesion - genetics | Neoplasm Invasiveness | Antineoplastic Agents, Phytogenic - chemistry | Plant Extracts - isolation & purification | Signal Transduction - genetics | Cell Adhesion - drug effects | Down-Regulation - drug effects | Luteolin - pharmacology | Cell Movement - drug effects | Luteolin - isolation & purification | Signal Transduction - drug effects | Breast Neoplasms - pathology | Antineoplastic Agents, Phytogenic - pharmacology | Antineoplastic Agents, Phytogenic - isolation & purification | Damping | Translocation | Transducers | Phosphorylation | Protein kinase C | Tumor cells | Invasiveness | Interleukin | Breast cancer | Acetate | Matrix metalloproteinase | Kinases | Cells | Nuclear transport | Metastases | Proteins | Tumours | Protein kinase | Acetic acid | Cancer | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Epigenetic regulation of mmp-9 gene expression
by Labrie, Marilyne and St-Pierre, Yves
Cellular and Molecular Life Sciences, ISSN 1420-682X, 9/2013, Volume 70, Issue 17, pp. 3109 - 3124
Matrix metalloproteinase 9 (MMP-9) is one of the most studied enzymes in cancer. MMP-9 can cleave proteins of the extracellular matrix and a large number of... 
Life Sciences | Biochemistry, general | Life Sciences, general | Epigenetics | DNA methylation | Histone | MMP-9 | Non-coding RNA | Biomedicine general | Cell Biology | Cancer | CANCER-CELLS | HISTONE DEACETYLASE INHIBITOR | ACTIVATED PROTEIN-KINASE | UROKINASE PLASMINOGEN-ACTIVATOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | NECROSIS-FACTOR-ALPHA | MATRIX-METALLOPROTEINASE EXPRESSION | CELL BIOLOGY | TISSUE INHIBITOR | NF-KAPPA-B | UP-REGULATION | Gene Expression Regulation, Enzymologic | Matrix Metalloproteinase 9 - metabolism | Neurodegenerative Diseases - physiopathology | Matrix Metalloproteinase 9 - genetics | Epigenesis, Genetic | Humans | Neoplasms - physiopathology | Gene Regulatory Networks | Genetic research | Enzymes | RNA | Methylation | Gene expression | Genes | Ribonucleic acid--RNA | Neurodegenerative Diseases | Human health and pathology | Infectious diseases | Neoplasms | Matrix Metalloproteinase 9
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Clusterin induces matrix metalloproteinase-9 expression via ERK1/2 and PI3K/Akt/NF-κB pathways in monocytes/macrophages
by Young-Jun Shim and Byeong-Ho Kang and Hye-Sook Jeon and In-Sun Park and Ki-Up Lee and In-Kyu Lee and Gil-Hong Park and Kyung-Mi Lee and Pepper Schedin and Bon-Hong Min
Journal of Leukocyte Biology, ISSN 0741-5400, 10/2011, Volume 90, Issue 4, pp. 761 - 769
Glycosylated secretory form of clusterin, but not non‐glycosylated intracellular clusterin, increases MMP‐9 activity and gene expression in... 
ECM remodeling | glycosylation | MMP‐9 | inflammation | tumor invasion | Glycosylation | Inflammation | MMP-9 | Tumor invasion | PROSTATE | MYOCARDITIS | IMMUNOLOGY | CANCER | CELL BIOLOGY | MATRIX METALLOPROTEINASES | THERAPY | CARCINOGENESIS | EPITHELIAL-CELLS | GENE-EXPRESSION | KAPPA-B PATHWAY | HEMATOLOGY | PROGRESSION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Mechanisms involved in enhancement of matrix metalloproteinase‐9 expression in macrophages by interleukin‐33
by Ariyoshi, Wataru and Okinaga, Toshinori and Chaweewannakorn, Wichida and Akifusa, Sumio and Nisihara, Tatsuji
Journal of Cellular Physiology, ISSN 0021-9541, 12/2017, Volume 232, Issue 12, pp. 3481 - 3495
IL‐33‐ST2L interaction increased MMP‐9 expression in RAW264.7 cells. ERK/CREB and NF‐κB cascades have an essential role in the induction of MMP‐9 in... 
interleukin‐33 (IL‐33) | macrophage | nuclear factor‐kappa B (NF‐κB) | matrix metalloproteinase‐9 (MMP‐9) | activator protein 1 (AP‐1) | matrix metalloproteinase-9 (MMP-9) | activator protein 1 (AP-1) | interleukin-33 (IL-33) | nuclear factor-kappa B (NF-κB) | nuclear factor-kappa B (NF-B) | 92-KDA GELATINASE | PHYSIOLOGY | MMP-9 EXPRESSION | IL-1 RECEPTOR | HUMAN MONOCYTES | CELL BIOLOGY | MATRIX METALLOPROTEINASES |